Therapeutic area

Respiratory, thoracic and mediastinal disorders – page 106

1 274 clinical trials
444 recruiting
379 conditions
28 countries

Clinical trials in Respiratory, thoracic and mediastinal disorders

1 274 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

1 274 clinical trials

Cardiovascular disorder+1

Not recruiting

Registered drug

Study of Prednisolone and Losartan in patients with heart inflammation after COVID-19 infection

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Losartan Potassium
Sponsor:Goethe University Frankfurt

Contact Research Centre

Acute respiratory distress syndrome+3

Not recruiting

Registered drugNo placebo

Study on Imlifidase for Patients with Severe ANCA-Associated Vasculitis and Lung Bleeding

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Imlifidase
Sponsor:Charite Universitaetsmedizin Berlin KöR

Contact Research Centre

Cystic fibrosis

Not recruiting

Registered drugNo placebo

Study on Long-term Safety and Efficacy of Elexacaftor, Tezacaftor, and Ivacaftor for Cystic Fibrosis in Patients Aged 12 Months and Older

Registered drugNo placebo

Denmark

Participants:0–17 years
Substances:Elexacaftor
Sponsor:Vertex Pharmaceuticals Inc.

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Brigatinib, Ceritinib, and Alectinib for Patients with Advanced ALK+ Non-Small Cell Lung Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Alectinib
Sponsor:Institut fuer Klinische Krebsforschung IKF GmbH

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing ONC-392 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After PD-1/PD-L1 Inhibitor Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Docetaxel
Sponsor:Oncoc4 Inc.

Contact Research Centre

Heritable pulmonary arterial hypertension+2

Not recruiting

Registered drug

Study on Dapagliflozin for Patients with Pulmonary Arterial Hypertension to Improve Exercise Capacity and Heart Function

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Dapagliflozin
Sponsor:Region Hovedstaden

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Volrustomig with a Drug Combination for Patients with Solid Tumors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:AstraZeneca AB

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Additional Chemotherapy with Osimertinib, Carboplatin, and Cisplatin for Patients with Advanced Non-Small Cell Lung Cancer and EGFR Mutation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Goethe University Frankfurt

Contact Research Centre

Renal cancer+4

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Atezolizumab with Radiotherapy for Patients with Metastatic Colorectal, Lung, Renal, and Sarcoma Cancers

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:Institut Gustave Roussy

Contact Research Centre

Asthma

Not recruiting

Registered drugNo placebo

Study on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Tezepelumab
Sponsor:AstraZeneca AB

Contact Research Centre

Alveolar proteinosis

Not recruiting

Investigational

Study of Inhaled Molgramostim for Adults with Autoimmune Pulmonary Alveolar Proteinosis

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Molgramostim
Sponsor:Savara ApS

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:AstraZeneca AB

Contact Research Centre

Substances studied in this area

The therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.

Carboplatin168 clinical trials Pembrolizumab143 clinical trials Cisplatin127 clinical trials Pemetrexed108 clinical trials Paclitaxel80 clinical trials Durvalumab71 clinical trials Atezolizumab50 clinical trials Sodium Chloride49 clinical trials Nivolumab48 clinical trials

Respiratory, thoracic and mediastinal disorders – page 106

Conditions in this area

Clinical trials in Respiratory, thoracic and mediastinal disorders

1 274 clinical trials

Cardiovascular disorder+1

Study of Prednisolone and Losartan in patients with heart inflammation after COVID-19 infection

Acute respiratory distress syndrome+3

Study on Imlifidase for Patients with Severe ANCA-Associated Vasculitis and Lung Bleeding

Cystic fibrosis

Study on Long-term Safety and Efficacy of Elexacaftor, Tezacaftor, and Ivacaftor for Cystic Fibrosis in Patients Aged 12 Months and Older

Non-small cell lung cancer

Study on Brigatinib, Ceritinib, and Alectinib for Patients with Advanced ALK+ Non-Small Cell Lung Cancer

Non-small cell lung cancer metastatic

Study Comparing ONC-392 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After PD-1/PD-L1 Inhibitor Treatment

Heritable pulmonary arterial hypertension+2

Study on Dapagliflozin for Patients with Pulmonary Arterial Hypertension to Improve Exercise Capacity and Heart Function

Non-small cell lung cancer

Study on the Safety and Effectiveness of Volrustomig with a Drug Combination for Patients with Solid Tumors

Non-small cell lung cancer

Study on Additional Chemotherapy with Osimertinib, Carboplatin, and Cisplatin for Patients with Advanced Non-Small Cell Lung Cancer and EGFR Mutation

Renal cancer+4

Study on the Effectiveness of Atezolizumab with Radiotherapy for Patients with Metastatic Colorectal, Lung, Renal, and Sarcoma Cancers

Asthma

Study on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma

Alveolar proteinosis

Study of Inhaled Molgramostim for Adults with Autoimmune Pulmonary Alveolar Proteinosis

Non-small cell lung cancer

Study on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.